Evidence map›Paper›PMID 41325132›Full record

ArticleHepatology communications2025

Five essential features for adoption of clinical risk prediction tools: Insights from the VOCAL-Penn score.

Kinza Khan, Mackenzie Bolas, Nadim Mahmud

Abstract read
In one paragraph

Article in Hepatology communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kinza KhanDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Mackenzie BolasCenter for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Nadim MahmudCenter for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-1889-3954

Funding

Improving Surgical Risk Prediction and Decision Making among Patients with CirrhosisK08DK124577 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MAHMUD, NADIM · 2021 to 2025
$835k
Understanding Patient Preferences for Surgical Management in the Setting of Cirrhosis: A Mixed-Methods ApproachR03DK134794 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MAHMUD, NADIM · 2024 to 2025
$244k
NIDDK NIH HHS K08 DK124577NIDDK NIH HHS R03 DK134794
6 · The paper itself

Abstract

backgroundAlthough medical risk prediction tools are widely developed, few achieve sustained clinical adoption. In cirrhosis patients, surgical risk calculators have achieved broad utilization. We sought to identify key design and implementation factors that influence provider uptake of such tools, using the VOCAL-Penn score (VPS) as a case example.

methodsWe conducted a qualitative study of 22 diverse clinicians who care for patients with cirrhosis. Semi-structured interviews were guided by the Consolidated Framework for Implementation Research to explore factors influencing the adoption of risk prediction tools. Interviews were transcribed and analyzed using a combined grounded theory and deductive approach. Emergent themes were synthesized into a conceptual framework.

resultsFive recurrent themes emerged as central: efficiency, accessibility, transparency, accuracy, and generalizability. Clinicians emphasized the need for tools that are intuitive, require minimal inputs, and integrate seamlessly into existing workflows. Ensuring input variables were clinically meaningful and readily available was cited as critical to encouraging use. Transparency in model development was essential to building trust. Participants stressed the importance of comparative performance data relative to existing clinical standards, as well as published external validations, to support the tool's credibility. Finally, generalizability was key to equitable application across diverse patient populations.

conclusionsUsing the VPS as a grounding example, our findings identify 5 domains-efficiency, accessibility, transparency, accuracy, and generalizability-that inform the development and dissemination of future tools. By aligning tool design with real-world clinical needs, this framework may support broader adoption and more equitable implementation of medical risk prediction tools.

Indexed as

Risk AssessmentHumansInterviews as TopicQualitative Researchcirrhosis careimplementation frameworkrisk calculatorsurgical risk assessment

Identifiers

PMID41325132
PMCPMC12668580

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.